Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and Sarcoma, Kaposi

pomalidomide has been researched along with Sarcoma, Kaposi in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
George, J; Goncalves, P; Lurain, K; Polizzotto, MN; Ramaswami, R; Steinberg, SM; Uldrick, TS; Whitby, D; Widell, A; Wyvill, KM; Yarchoan, R1
Jensen, SMR; Krug, LT; Lurain, K; Polizzotto, MN; Ramaswami, R; Sereti, I; Shoemaker, G; Singh, A; Uldrick, TS; Wyvill, KM; Yarchoan, R1
Burki, TK1
Aleman, K; Bevans, M; Figg, WD; Goncalves, PH; Khetani, V; Maldarelli, F; Marshall, V; Peer, CJ; Polizzotto, MN; Sereti, I; Steinberg, SM; Uldrick, TS; Whitby, D; Wyvill, KM; Yarchoan, R; Zeldis, JB1

Trials

3 trial(s) available for pomalidomide and Sarcoma, Kaposi

ArticleYear
Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, Mar-01, Volume: 28, Issue:5

    Topics: Anticoagulants; Herpesvirus 8, Human; HIV Infections; Humans; Sarcoma, Kaposi; Thalidomide; Venous Thromboembolism

2022
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.
    AIDS (London, England), 2023, 09-01, Volume: 37, Issue:11

    Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Sarcoma, Kaposi; T-Lymphocyte Subsets

2023
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Volume: 34, Issue:34

    Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; HIV Infections; Humans; Male; Middle Aged; Quality of Life; Sarcoma, Kaposi; Thalidomide; Treatment Outcome

2016

Other Studies

1 other study(ies) available for pomalidomide and Sarcoma, Kaposi

ArticleYear
Pomalidomide for symptomatic Kaposi's sarcoma.
    The Lancet. Oncology, 2016, Volume: 17, Issue:12

    Topics: Antineoplastic Agents, Immunological; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide; Treatment Outcome

2016